Alexandra Gangi1, James R Howe2. 1. Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, 8700 Beverly Blvd, AC 1049, Los Angeles, CA, 90048, USA. 2. Surgical Oncology and Endocrine Surgery, University of Iowa Carver College of Medicine, University of Iowa Hospitals and Clinics, 4644 JCP, 200 Hawkins Drive, Iowa City, IA, 52242, USA. james-howe@uiowa.edu.
Abstract
BACKGROUND: Neuroendocrine tumors are becoming increasingly prevalent, with many patients presenting with or developing metastatic disease to the liver. METHODS: In this landmark series paper, we highlight the critical studies that have defined the surgical management of neuroendocrine tumor liver metastases, as well as several randomized control trials which have investigated strategies for systemic control of metastatic disease. RESULTS: Liver-directed surgical approaches and locally ablative procedures are recommended for patients with limited, resectable, and in some cases, nonresectable tumor burden. Angiographic liver-directed techniques, such as transarterial embolization, chemoembolization, and radioembolization, offer another approach for management in patients with liver-predominant disease. Peptide receptor radionuclide therapy is a promising therapy for patients with hepatic and/or extrahepatic metastases. Various systemic medical therapies are also available as adjunct or definitive therapy for patients with metastatic disease. CONCLUSIONS: This article reviews current data regarding management of neuroendocrine liver metastases and highlights areas for future study.
BACKGROUND:Neuroendocrine tumors are becoming increasingly prevalent, with many patients presenting with or developing metastatic disease to the liver. METHODS: In this landmark series paper, we highlight the critical studies that have defined the surgical management of neuroendocrine tumor liver metastases, as well as several randomized control trials which have investigated strategies for systemic control of metastatic disease. RESULTS: Liver-directed surgical approaches and locally ablative procedures are recommended for patients with limited, resectable, and in some cases, nonresectable tumor burden. Angiographic liver-directed techniques, such as transarterial embolization, chemoembolization, and radioembolization, offer another approach for management in patients with liver-predominant disease. Peptide receptor radionuclide therapy is a promising therapy for patients with hepatic and/or extrahepatic metastases. Various systemic medical therapies are also available as adjunct or definitive therapy for patients with metastatic disease. CONCLUSIONS: This article reviews current data regarding management of neuroendocrine liver metastases and highlights areas for future study.
Authors: Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar Journal: Neuroendocrinology Date: 2012-02-15 Impact factor: 4.914
Authors: Skye C Mayo; Mechteld C de Jong; Carlo Pulitano; Brian M Clary; Srinevas K Reddy; T Clark Gamblin; Scott A Celinksi; David A Kooby; Charles A Staley; Jayme B Stokes; Carrie K Chu; Alessandro Ferrero; Richard D Schulick; Michael A Choti; Giles Mentha; Jennifer Strub; Todd W Bauer; Reid B Adams; Luca Aldrighetti; Lorenzo Capussotti; Timothy M Pawlik Journal: Ann Surg Oncol Date: 2010-06-29 Impact factor: 5.344
Authors: M Cives; M Ghayouri; B Morse; M Brelsford; M Black; A Rizzo; A Meeker; J Strosberg Journal: Endocr Relat Cancer Date: 2016-09 Impact factor: 5.678
Authors: Roberto Gedaly; Michael F Daily; Daniel Davenport; Patrick P McHugh; Alvaro Koch; Paul Angulo; Jonathan C Hundley Journal: Arch Surg Date: 2011-08
Authors: Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que Journal: J Am Coll Surg Date: 2003-07 Impact factor: 6.113
Authors: Sheung Tat Fan; Yves Patrice Le Treut; Vincenzo Mazzaferro; Andrew K Burroughs; Michael Olausson; Stefan Breitenstein; Andrea Frilling Journal: HPB (Oxford) Date: 2014-07-03 Impact factor: 3.647
Authors: Paul Rogowski; Rieke von Bestenbostel; Franziska Walter; Katrin Straub; Lukas Nierer; Christopher Kurz; Guillaume Landry; Michael Reiner; Christoph Josef Auernhammer; Claus Belka; Maximilian Niyazi; Stefanie Corradini Journal: Cancers (Basel) Date: 2021-03-26 Impact factor: 6.639